What is the recommended tapering schedule for discontinuing clonazepam (Klonopin) in a patient taking 0.25 mg at night, and is switching to every other day dosing an effective approach?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tapering Clonazepam in a Patient Taking 0.25 mg at Night

The recommended approach for discontinuing clonazepam 0.25 mg at night is to reduce the dose by 0.125 mg every 3 days until the medication is completely withdrawn, rather than switching to every other day dosing. 1

General Tapering Principles

  • The FDA-approved label for clonazepam specifically recommends discontinuing treatment gradually, with a decrease of 0.125 mg twice daily every 3 days, until the drug is completely withdrawn 1
  • For patients on low doses like 0.25 mg nightly, this translates to reducing by 0.125 mg (half the dose) every 3 days, which would mean:
    • Days 1-3: 0.25 mg nightly
    • Days 4-6: 0.125 mg nightly
    • Day 7: Discontinue

Why Every Other Day Dosing Is Not Recommended

  • Alternating day dosing is not mentioned in the FDA labeling for clonazepam discontinuation 1
  • Every other day dosing can lead to fluctuating blood levels due to clonazepam's long half-life (22-32 hours), potentially causing intermittent withdrawal symptoms 2
  • This approach may cause more withdrawal discomfort than a consistent gradual dose reduction 3

Evidence-Based Tapering Approaches

  • Research shows that clonazepam can be successfully discontinued without major withdrawal symptoms when the dose is reduced gradually 3
  • For patients on higher doses, a reduction of 0.25 mg per week has been shown to be effective after reaching 1 mg daily 3
  • For very low doses like 0.25 mg, the final reduction may need to be even slower, potentially using a liquid formulation or tablet splitting to achieve smaller dose decrements 4

Managing Withdrawal Symptoms

  • Monitor for common withdrawal symptoms which may include anxiety, tremor, insomnia, nausea, irritability, and sweating 3
  • If severe withdrawal symptoms occur, return to the previous well-tolerated dose and slow the taper further 5, 4
  • For patients who have been on clonazepam for extended periods (years), an even slower taper of 10% per month might be better tolerated 5, 4

Special Considerations

  • The CDC recommends that when tapering benzodiazepines, a decrease of 10% of the original dose per week is a reasonable starting point, though this may need to be adjusted based on individual response 6
  • For patients who have been on clonazepam for longer durations, slower tapers might be more appropriate and better tolerated 6, 5
  • Tapers may need to be paused if the patient experiences significant withdrawal symptoms, and can be restarted when the patient is ready 4

Potential Pitfalls to Avoid

  • Avoid abrupt discontinuation, which increases risk of withdrawal symptoms 1
  • Do not use a rigid "one-size-fits-all" approach; be prepared to adjust the tapering schedule based on individual response 5, 4
  • Recognize that patients on even low doses like 0.25 mg may experience withdrawal symptoms, particularly if they've been taking the medication for an extended period 3

References

Research

Clonazepam. A review of a new anticonvulsant drug.

Archives of neurology, 1976

Guideline

Tapering Aripiprazole

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tapering Antipsychotics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.